Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Smith

Showing results (341-350 of 368) with videos related to

Pageof 37
Sort By:
Bio/Technology (Nature Publishing Company)|June 1, 1992
Functional expression of GABAA chloride channels and benzodiazepine binding sites in baculovirus infected insect cellsD B Carter, D R Thomsen, W B Im, et al.
European Journal of Pharmacology|March 19, 1997
Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptorS K Schlachter, T J Poel, C F Lawson, et al.
Genes and Immunity|April 9, 2005
Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearanceT K Oleksyk, C L Thio, A L Truelove, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivativesC H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry|July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availabilityC H Lin, S R Haadsma-Svensson, G Phillips, et al.
Genomics|September 1, 1993
A sequence-tagged site map of human chromosome 11M W Smith, S P Clark, J S Hutchinson, et al.
Drug Design and Discovery|January 1, 1993
Medicinal chemistry of imidazoquinolinone dopamine receptor agonistsM W Moon, J K Morris, R F Heier, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.
British Journal of Haematology|June 19, 2001
Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot studyC B Foster, S Zhu, H C Erichsen, et al.
Journal of Medicinal Chemistry|June 1, 1991
Naphtho and benzo analogues of the kappa opioid agonist trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamideJ P Freeman, E T Michalson, S V D'Andrea, et al.
Pageof 37

Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Bio/Technology (Nature Publishing Company)|June 1, 1992
Functional expression of GABAA chloride channels and benzodiazepine binding sites in baculovirus infected insect cellsD B Carter, D R Thomsen, W B Im, et al.
European Journal of Pharmacology|March 19, 1997
Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptorS K Schlachter, T J Poel, C F Lawson, et al.
Genes and Immunity|April 9, 2005
Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearanceT K Oleksyk, C L Thio, A L Truelove, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivativesC H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry|July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availabilityC H Lin, S R Haadsma-Svensson, G Phillips, et al.
Genomics|September 1, 1993
A sequence-tagged site map of human chromosome 11M W Smith, S P Clark, J S Hutchinson, et al.
Drug Design and Discovery|January 1, 1993
Medicinal chemistry of imidazoquinolinone dopamine receptor agonistsM W Moon, J K Morris, R F Heier, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.
British Journal of Haematology|June 19, 2001
Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot studyC B Foster, S Zhu, H C Erichsen, et al.
Journal of Medicinal Chemistry|June 1, 1991
Naphtho and benzo analogues of the kappa opioid agonist trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamideJ P Freeman, E T Michalson, S V D'Andrea, et al.
Pageof 37